Regeneron Pharmaceuticals, Inc. (REGN)

NMS – Real Time Price. Currency in USD

794.63

-2.38 (-0.30%)

Market open: Aug 12, 2026, 1:13 PM EDT

800.00

+3.00 (0.38%)

Previous after-hours: Aug 11, 2026, 7:55 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

14.34B

14.20B

13.12B

12.17B

Cost of goods sold

-2.64B

-2.45B

-2.24B

-1.71B

Gross Profit

11.70B

11.75B

10.87B

10.47B

Operating expenses (excl. COGS)

-8B

-7.58B

-6.52B

-5.08B

Operating Income

3.70B

4.17B

4.35B

5.39B

Non-operating income, total

1.53B

606M

-149M

-527M

Pretax income

5.23B

4.78B

4.20B

4.86B

Equity in earnings

Taxes

-726M

-367M

-246M

-520M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

4.50B

4.41B

3.95B

4.34B

Discontinued operations

Net income

4.50B

4.41B

3.95B

4.34B

Dilution adjustment

Preferred dividends

Regeneron Pharmaceuticals, Inc. (REGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Regeneron Pharmaceuticals, Inc. (REGN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Regeneron Pharmaceuticals, Inc. (REGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Regeneron Pharmaceuticals, Inc. (REGN)

Income Statement (Annual)

Income Statement (Annual)